243 related articles for article (PubMed ID: 28413861)
41. Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model.
Liao N; Shi Y; Wang Y; Liao F; Zhao B; Zheng Y; Zeng Y; Liu X; Liu J
Stem Cell Res Ther; 2020 Jun; 11(1):237. PubMed ID: 32546282
[TBL] [Abstract][Full Text] [Related]
42. Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats.
Li T; Zhu J; Ma K; Liu N; Feng K; Li X; Wang S; Bie P
J Surg Res; 2013 Oct; 184(2):1161-73. PubMed ID: 23809154
[TBL] [Abstract][Full Text] [Related]
43. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.
Tsai PC; Fu TW; Chen YM; Ko TL; Chen TH; Shih YH; Hung SC; Fu YS
Liver Transpl; 2009 May; 15(5):484-95. PubMed ID: 19399744
[TBL] [Abstract][Full Text] [Related]
44. A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-β1 and Suppresses Ongoing Hepatic Fibrosis.
Li Y; Wang W; Jia X; Zhai S; Wang X; Wang Y; Dang S
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):305-15. PubMed ID: 25740471
[TBL] [Abstract][Full Text] [Related]
45.
Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
[TBL] [Abstract][Full Text] [Related]
46. Human bone marrow-derived mesenchymal stromal cells in combination with silymarin regulate hepatocyte growth factor expression and genotoxicity in carbon tetrachloride induced hepatotoxicity in Wistar rats.
Aithal AP; Bairy LK; Seetharam RN; Rao MK
J Cell Biochem; 2019 Aug; 120(8):13026-13036. PubMed ID: 30873677
[TBL] [Abstract][Full Text] [Related]
47. Transplantation of mesenchymal stem cells expressing TIMP-1-shRNA improves hepatic fibrosis in CCl₄-treated rats.
Zhu Y; Miao Z; Gong L; Chen W
Int J Clin Exp Pathol; 2015; 8(8):8912-20. PubMed ID: 26464632
[TBL] [Abstract][Full Text] [Related]
48. Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis.
Choi HS; Kang JW; Lee SM
Transl Res; 2015 Sep; 166(3):292-303. PubMed ID: 25936762
[TBL] [Abstract][Full Text] [Related]
49. Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.
Shen X; Cheng S; Peng Y; Song H; Li H
BMC Complement Altern Med; 2014 Oct; 14():418. PubMed ID: 25345787
[TBL] [Abstract][Full Text] [Related]
50. Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis.
Jang YO; Kim SH; Cho MY; Kim KS; Park KS; Cha SK; Kim MY; Chang SJ; Baik SK
Biochem Biophys Res Commun; 2018 Feb; 497(1):264-271. PubMed ID: 29428718
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.
Farouk S; Sabet S; Abu Zahra FA; El-Ghor AA
PLoS One; 2018; 13(10):e0206130. PubMed ID: 30346985
[TBL] [Abstract][Full Text] [Related]
52. [Comparison of biological characteristics of bone marrow mesenchymal stem cells cultured in vitro from SD rats and BALB/c mice].
Zou W; Zhao J; Li Y; Hu T; Wang Y; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Dec; 34(12):1099-1104. PubMed ID: 30626476
[TBL] [Abstract][Full Text] [Related]
53. Melatonin promotes hepatic differentiation of human dental pulp stem cells: clinical implications for the prevention of liver fibrosis.
Cho YA; Noh K; Jue SS; Lee SY; Kim EC
J Pineal Res; 2015 Jan; 58(1):127-35. PubMed ID: 25431168
[TBL] [Abstract][Full Text] [Related]
54. Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model.
Yu J; Yin S; Zhang W; Gao F; Liu Y; Chen Z; Zhang M; He J; Zheng S
Stem Cell Res Ther; 2013 Jul; 4(4):83. PubMed ID: 23856418
[TBL] [Abstract][Full Text] [Related]
55. Mesenchymal stem cells: In vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats.
Raafat N; Abdel Aal SM; Abdo FK; El Ghonaimy NM
Int J Biochem Cell Biol; 2015 Nov; 68():109-18. PubMed ID: 26369870
[TBL] [Abstract][Full Text] [Related]
56. Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice.
Crespo I; San-Miguel B; Fernández A; Ortiz de Urbina J; González-Gallego J; Tuñón MJ
Transl Res; 2015 Feb; 165(2):346-57. PubMed ID: 25445210
[TBL] [Abstract][Full Text] [Related]
57. Hepatocyte-like Versus Mesenchymal Stem Cells in CCl4-induced Liver Fibrosis.
Ewida SF; Abdou AG; El-Rasol Elhosary AA; El-Ghane Metawe SA
Appl Immunohistochem Mol Morphol; 2017; 25(10):736-745. PubMed ID: 27153445
[TBL] [Abstract][Full Text] [Related]
58. Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
Arango JC; Puerta-Arias JD; Pino-Tamayo PA; Salazar-Peláez LM; Rojas M; González Á
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006006. PubMed ID: 29040281
[TBL] [Abstract][Full Text] [Related]
59. Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis.
Kang JW; Hong JM; Lee SM
J Pineal Res; 2016 May; 60(4):383-93. PubMed ID: 26882442
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
